Rochester- October 2024- A $25 million gift from the Louis V. Gerstner, Jr. family will establish the Gerstner Scholars Program in AI Translation at Mayo Clinic. Through this program, junior and early-career clinicians and clinician-investigators will collaborate with leading experts in artificial intelligence (AI), data science and informatics to drive breakthrough cures for patients.
“We are deeply grateful to Lou and Robin Gerstner for their long-standing friendship and support,” says Gianrico Farrugia, M.D., Mayo Clinic’s president and CEO. “Lou’s remarkable generosity over many years has been instrumental in pushing the boundaries of innovation, allowing us to deliver the best care to our patients. This gift further empowers our clinicians to lead practice-changing advancements in healthcare through the strategic and ethical application of AI.”
“AI holds incredible promise for the future of medicine, but it takes more than just algorithms to make that promise a reality,” says Mr. Gerstner. “It requires a commitment to innovation and to the talented individuals who can turn theory into practice. By creating the Gerstner Scholars Program at Mayo Clinic, we ensure that clinicians with patient-first strategies have what they need to redefine what’s possible in healthcare.”
Mayo Clinic established Mayo Clinic Platform, the first true platform in healthcare, in part to advance AI innovations globally and ensure these solutions reach patients everywhere. Mayo Clinic Platform is enabling the development and integration of AI solutions in a massively scalable and meaningful way, with more than 250 AI solutions in use or under development at Mayo Clinic alone. Supported by the world’s largest privacy-protected global dataset, these solutions focus on enhancing early disease detection, improving treatment accuracy and supporting diagnostics. Moreover, Mayo Clinic is a leader in responsible and ethical AI and is committed to patient-centric solutions, with rigorous safety, regulatory and privacy measures, including physician oversight of all patient care solutions.
Also Read: Mayo Clinic Wins ARPA-H Award to Develop Living Pharmacy for Inflammatory Disease
The Gerstner Scholars Program will accelerate these advancements by providing critical funding and dedicated time for clinicians to pursue high-impact AI projects across Mayo Clinic and ensure more AI-powered solutions are available to patients.
“Mayo Clinic is a leader in artificial intelligence in healthcare because we are able to translate innovation into real solutions for our patients earlier in their care journeys,” says Matthew R. Callstrom, M.D., Ph.D., Mayo Clinic’s medical director for Strategy, chair of Radiology in Rochester, and leader of the Generative Artificial Intelligence Program. “We are profoundly grateful to Mr. Gerstner for this visionary gift. The Gerstner Scholars Program empowers us to stay at the forefront of healthcare transformation by investing in our world-leading staff.”
